(LEAD) SK Biopharm's Q3 operating profit up 66 pct on U.S. sales of seizure drug

Told by 1 newspaper in one country, at 02:00 on 5 November 2026.

In this story

In short

South Korea's SK Biopharm reported that its third-quarter operating profit rose 66% on U.S. sales of a seizure medication.1

AIMade at 02:36, only from the headlines. Each number links to the source headline. How it is made

Each headline is the original, as the newspaper published it, in the order it arrived. The selection follows the public grouping rule, with no AI.

Yonhap · South Korea · 02:16(LEAD) SK Biopharm's Q3 operating profit up 66 pct on U.S. sales of seizure drugRead at the newspaper ↗